Dom Coric, MD
Carolinas Medical Center is now the second clinical study site in the United States testing the safety and potential effectiveness of the Neuro-Spinal Scaffold, an investigational device intended to improve recovery after a spinal cord injury (SCI) by promoting structural support for spinal cord regeneration.
Many SCIs are caused by traumatic events, such as automobile accidents, but currently there is no effective treatment for paralysis attributed to SCI.
The co-principal investigators of the study are Dom Coric, MD, chief of neurosurgery at CMC, and William Bockenek, MD, chief medical officer of Carolinas Rehabilitation and chairman of the department of physical medicine and rehabilitation at CMC.
William Bockenek, MD
This is the first clinical study of the the Neuro-Spinal Scaffold, the device made by InVivo Therapeutics. The pilot study is intended to capture preliminary safety and effectiveness data of the scaffold in up to five subjects with acute SCI. CMC is now enrolling patients in the study.
As the first in-human study of InVivo’s device, this study is a critical step in addressing a major unmet need for patients with SCI. In early animal studies, the use of the Neuro-Spinal Scaffold promoted new nerve growth and improved muscle function.
“There is early evidence that this device and surgical treatment can potentially enhance the quality of life for our patients with spinal cord injuries,” said Dr. Bockenek. “The fact that Carolinas Medical Center was chosen as a study site proves we are on the forefront of spinal cord research, and we continue to make efforts to enhance the patient care we provide.”